Skip to main content
Clinical Trials/ACTRN12605000169640
ACTRN12605000169640
Active, not recruiting
Phase 2

A randomised pilot study assessing tumor response by investigating the optimum timing of gemcitabine and concurrent radiation therapy after induction gemcitabine and carboplatin for locally advanced non-small cell lung cancer

Princess Alexandra Hospital0 sites24 target enrollmentAugust 17, 2005

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Advanced non-small cell lung cancer
Sponsor
Princess Alexandra Hospital
Enrollment
24
Status
Active, not recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 17, 2005
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Histologically or cytologically proven non\-small cell lung cancer.\-Planned moderate dose radiation therapy for locoregional control. \-Patients found to have a locally advanced thoracic disease suitable for radical therapy but on work up are found to have solitary metastasis. If in the brain the metastasis must be operable\-Patients must have measurable disease on imaging scans.

Exclusion Criteria

  • History of any other cancer (except non\-melanoma skin cancer or carcinoma in situ of the cervix) unless in complete remission and off all therapy for that cancer for at least 5 years.\-Receiving treatment with another investigational agent.

Outcomes

Primary Outcomes

Not specified

Similar Trials